To determine the clinical impact of HSP90B1 3′UTR polymorphism in CLL, we screened 165 additional patients with CLL and 32 healthy controls for this polymorphism by pyrosequencing. The gene discussed is HSP90B1; the disease is B-cell chronic lymphocytic leukemia.